Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hamilton Thorne Ltd (TSE:HTL)
TSX:HTL
Holding TSE:HTL?
Track your performance easily
HTL Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$1.05 - C$2.20
Previous CloseC$2.14
Volume1.18M
Average Volume (3M)272.60K
Market Cap
C$329.35M
Enterprise ValueC$338.59M
Total Cash (Recent Filing)$15.29M
Total Debt (Recent Filing)$22.09M
Price to Earnings (P/E)―
Beta-0.29
Next Earnings
Nov 21, 2024EPS Estimate
<C$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding153,902,476
10 Day Avg. Volume82,677
30 Day Avg. Volume272,595
Standard Deviation0.10
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)5.78
Price to Sales (P/S)4.97
Price to Cash Flow (P/CF)N/A
P/FCF Ratio164.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.19
Enterprise Value/Gross Profit11.64
Enterprise Value/Ebitda94.01
Forecast
1Y Price Target
C$2.28Price Target Upside3.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Hamilton Thorne News
PremiumCompany Announcements
Hamilton Thorne Set for Private Transition and Expansion
PremiumCompany Announcements
Hamilton Thorne Proposes Going-Private Deal and Acquisition
PremiumCompany Announcements
Hamilton Thorne Confirms Growth and Annual Targets
PremiumCompany Announcements
Hamilton Thorne Announces Q2 2024 Financial Results DateBulls Say, Bears Say
Bulls Say
Financial PerformanceGross margin expanded to 52.4%, and Adj. EBITDA increased 24.4% year-over-year to $3.5M, as cost reduction strategies introduced in Q4 begin to bear fruit.
Market PositionAnalyst maintains a Buy rating and C$2.45/shr price target, expecting the attractive growth characteristics of the IVF market and HTL’s strong competitive position to reward shareholders over the long-term.
Mergers And AcquisitionsHTL has a solid financial position with a cash balance of $7.5M and $4.5M undrawn on its lines of credit, supporting a robust M&A pipeline.
Bears Say
EarningsQ423 results missed on the topline but beat expectations on adj. EBITDA.
RevenueQ423 results missed on the topline with revenue falling below ECM and consensus estimates.
Sales PerformanceQ423 sales increased 12.3% y/y but were below ECM estimate and consensus and below its Q4 guidance of 9-10% organic growth.
---
Options Prices
Currently, No data available
---
Ownership Overview
49.28% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
50.70% Public Companies and
Individual Investors
HTL FAQ
What was Hamilton Thorne Ltd’s price range in the past 12 months?
Hamilton Thorne Ltd lowest stock price was C$1.05 and its highest was C$2.20 in the past 12 months.
What is Hamilton Thorne Ltd’s market cap?
Currently, no data Available
When is Hamilton Thorne Ltd’s upcoming earnings report date?
Hamilton Thorne Ltd’s upcoming earnings report date is Nov 21, 2024 which is in 63 days.
How were Hamilton Thorne Ltd’s earnings last quarter?
Hamilton Thorne Ltd released its earnings results on Aug 14, 2024. The company reported C$0 earnings per share for the quarter, missing the consensus estimate of C$0.007 by -C$0.007.
Is Hamilton Thorne Ltd overvalued?
According to Wall Street analysts Hamilton Thorne Ltd’s price is currently Undervalued.
Does Hamilton Thorne Ltd pay dividends?
Hamilton Thorne Ltd does not currently pay dividends.
What is Hamilton Thorne Ltd’s EPS estimate?
Hamilton Thorne Ltd’s EPS estimate is <C$0.01.
How many shares outstanding does Hamilton Thorne Ltd have?
Hamilton Thorne Ltd has 153,902,480 shares outstanding.
What happened to Hamilton Thorne Ltd’s price movement after its last earnings report?
Hamilton Thorne Ltd reported an EPS of C$0 in its last earnings report, missing expectations of C$0.007. Following the earnings report the stock price went up 0.483%.
Which hedge fund is a major shareholder of Hamilton Thorne Ltd?
Currently, no hedge funds are holding shares in TSE:HTL
---
Hamilton Thorne Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$2.28 (3.64% Upside)
C$2.28 (3.64% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
57.35%
12-Months-Change
Fundamentals
Return on Equity
-2.79%
Trailing 12-Months
Asset Growth
22.22%
Trailing 12-Months
Company Description
Hamilton Thorne Ltd
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has single reporting segment being Engaged in Sales to the ART, Research and Cell Biology Markets.
---
HTL Stock 12 Month Forecast
Average Price Target
C$2.28
▲(3.64% Upside)
Technical Analysis
Best Analysts Covering HTL
1 Year
1 Year Success Rate
12/30 ratings generated profit
1 Year Average Return
+9.99%
reiterated a buy rating 2 months ago
Copying Justin Keywood's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +9.99% per trade.
---